Wall Street Zen Upgrades Veeva Systems to Buy

Analysts cite strong product portfolio and growth potential for the cloud software company.

Mar. 14, 2026 at 5:50am

Got story updates? Submit your updates here. ›

Veeva Systems (NYSE:VEEV), a cloud software company serving the global life sciences industry, was upgraded from a "hold" rating to a "buy" rating by analysts at Wall Street Zen. The upgrade comes as Veeva continues to expand its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities for pharmaceutical, biotechnology, medical device, and consumer health companies.

Why it matters

Veeva's cloud-based solutions have become increasingly essential for life sciences companies navigating complex regulatory environments and data management needs. The upgrade by Wall Street Zen suggests analysts see further growth potential for Veeva as it continues to innovate and expand its product offerings.

The details

In their research report, Wall Street Zen analysts cited Veeva's strong product portfolio and growth trajectory as reasons for the upgrade. The company has steadily expanded its Vault platform and related suites, which are used by a growing number of pharmaceutical, biotech, and medical device firms to manage regulated content, clinical trials, quality systems, and commercial operations.

  • Veeva Systems was upgraded from a "hold" rating to a "buy" rating on Saturday, March 14, 2026.

The players

Veeva Systems

A cloud software company that develops industry-specific applications and data solutions for the global life sciences sector, founded in 2007 and headquartered in Pleasanton, California.

Wall Street Zen

An equity research firm that provides investment analysis and recommendations to clients.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

The takeaway

Veeva's continued innovation and expansion of its cloud-based solutions for the life sciences industry have caught the attention of Wall Street analysts, who see strong growth potential for the company going forward.